| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |